Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-03-28 @ 8:35 AM
Study NCT ID:
NCT04139304
Status:
RECRUITING
Last Update Posted:
2025-06-29
First Post:
2019-10-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Sponsor:
AIDS Malignancy Consortium
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Plasmablastic Lymphoma | View |
| None | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | View |
| None | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | View |
| None | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | View |
| None | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | View |
Keywords: